Completed PHASE2 INTERVENTIONAL 1-arm NCT01445769

Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis

An Open-label Assessment of an Alternative Dosing Strategy of Ruxolitinib in Patients With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, and Post-essential Thrombocythemia Myelofibrosis

Sponsor: Incyte Corporation

Conditions Post-Essential Thrombocythemia Myelofibrosis Post-Polycythemia Vera Myelofibrosis Primary Myelofibrosis

Interventions Ruxolitinib

Updated 8 times since 2017 Last updated: Mar 18, 2019 Started: Sep 30, 2011 Primary completion: Mar 31, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Post-Essential Thrombocythemia Myelofibrosis and Post-Polycythemia Vera Myelofibrosis and is currently completed. Incyte Corporation leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2
Apr 2019 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Apr 2019 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Incyte Corporation

Data source: Incyte Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Armonk, United States , Atlanta, United States , Augusta, United States , Baltimore, United States , Canton, United States , Charleston, United States , Hazleton, United States , Hershey, United States , Hickory, United States and 11 more locations